SE8600202D0 - Farmaceutisk komposition (ii) - Google Patents
Farmaceutisk komposition (ii)Info
- Publication number
- SE8600202D0 SE8600202D0 SE8600202A SE8600202A SE8600202D0 SE 8600202 D0 SE8600202 D0 SE 8600202D0 SE 8600202 A SE8600202 A SE 8600202A SE 8600202 A SE8600202 A SE 8600202A SE 8600202 D0 SE8600202 D0 SE 8600202D0
- Authority
- SE
- Sweden
- Prior art keywords
- pharmaceutical composition
- new
- compound
- relates
- present
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8400085A SE457505B (sv) | 1984-01-10 | 1984-01-10 | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8600202L SE8600202L (sv) | 1986-01-17 |
SE8600202D0 true SE8600202D0 (sv) | 1986-01-17 |
SE462529B SE462529B (sv) | 1990-07-09 |
Family
ID=20354249
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8400085A SE457505B (sv) | 1984-01-10 | 1984-01-10 | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
SE8600202A SE462529B (sv) | 1984-01-10 | 1986-01-17 | Metoprololsuccinat samt farmaceutisk komposition innehaallande detsamma |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8400085A SE457505B (sv) | 1984-01-10 | 1984-01-10 | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
Country Status (7)
Country | Link |
---|---|
US (2) | US4780318A (sv) |
EP (2) | EP0148811B1 (sv) |
AT (2) | ATE46080T1 (sv) |
DE (2) | DE3572767D1 (sv) |
HK (1) | HK24995A (sv) |
SE (2) | SE457505B (sv) |
SG (1) | SG2295G (sv) |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57500432A (sv) * | 1980-03-20 | 1982-03-11 | ||
US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
JPS6261916A (ja) * | 1985-09-12 | 1987-03-18 | Fujisawa Pharmaceut Co Ltd | 持続性製剤 |
SE450087B (sv) * | 1985-10-11 | 1987-06-09 | Haessle Ab | Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial |
SE455836B (sv) | 1985-10-11 | 1988-08-15 | Haessle Ab | Beredning med kontrollerad frisettning innehallande ett salt av metoprolol samt metod for framstellning av denna beredning |
US4717567A (en) * | 1985-11-25 | 1988-01-05 | Eastman Kodak Company | Rumen-stable pellets |
GB2186485B (en) * | 1986-02-13 | 1988-09-07 | Ethical Pharma Ltd | Slow release formulation |
US5238686A (en) * | 1986-03-27 | 1993-08-24 | Kinaform Technology, Inc. | Sustained-release pharmaceutical preparation |
AU591248B2 (en) * | 1986-03-27 | 1989-11-30 | Kinaform Technology, Inc. | Sustained-release pharaceutical preparation |
KR910002669B1 (ko) * | 1986-12-25 | 1991-05-03 | 데이산세이야꾸 가부시끼가이샤 | 서방성 과립 및 그를 함유하는 지속성 복합과립 |
SE460945B (sv) * | 1987-01-15 | 1989-12-11 | Lejus Medical Ab | En multipel-unit-dos komposition av furosemid |
US4789549A (en) * | 1987-03-09 | 1988-12-06 | Warner-Lambert Company | Sustained release dosage forms |
SE460946B (sv) * | 1987-03-16 | 1989-12-11 | Lejus Medical Ab | En multipel-unit-dos komposition av kinidinglukonat |
SE8703881D0 (sv) * | 1987-10-08 | 1987-10-08 | Haessle Ab | New pharmaceutical preparation |
IL88083A (en) * | 1987-11-06 | 1992-11-15 | Tanabe Seiyaku Co | Controlled release pharmaceutical dosage form and its preparation |
FR2624732B1 (fr) * | 1987-12-21 | 1991-02-15 | Synthelabo | Formulation pharmaceutique a liberation prolongee |
US4971805A (en) * | 1987-12-23 | 1990-11-20 | Teysan Pharmaceuticals Co., Ltd. | Slow-releasing granules and long acting mixed granules comprising the same |
FI101344B (sv) * | 1988-03-31 | 1998-06-15 | Tanabe Seiyaku Co | Förfarande för framställning av ett preparat för kontrollerat frigörin g av ett farmaceutiskt aktivt ämne |
US4892739A (en) * | 1988-04-25 | 1990-01-09 | Ciba-Geigy Corporation | Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties |
FR2634376B1 (fr) * | 1988-07-21 | 1992-04-17 | Farmalyoc | Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation |
EP0352800A3 (en) * | 1988-07-28 | 1991-05-08 | Warner-Lambert Company | Aqueous polymeric dispersion of cellulosic and acrylic based polymers for preparing pharmaceutical dosage forms and dosage forms thereof |
US5296236A (en) * | 1988-09-16 | 1994-03-22 | Recordati S.A., Chemical And Pharmaceutical Company | Controlled release therapeutic system for a liquid pharmaceutical formulations |
GB8913889D0 (en) * | 1989-06-16 | 1989-08-02 | May & Baker Ltd | New compositions of matter |
US5422881A (en) * | 1989-06-30 | 1995-06-06 | Inmos Limited | Message encoding |
GB8915137D0 (en) * | 1989-06-30 | 1989-08-23 | Inmos Ltd | Message routing |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
EP0458751A1 (en) * | 1990-05-25 | 1991-11-27 | Warner-Lambert Company | Delivery system for cyclic amino acids with improved taste, texture and compressibility |
DE69118188T2 (de) * | 1990-07-26 | 1996-10-31 | Monsanto Co., St. Louis, Mo. | Verfahren zur herstellung vernetzter polyamine |
US5316772A (en) * | 1990-12-19 | 1994-05-31 | Solvay & Cie, S.A. (Societe Anonyme) | Bilayered oral pharmaceutical composition with pH dependent release |
US6764697B1 (en) | 1991-06-27 | 2004-07-20 | Alza Corporation | System for delaying drug delivery up to seven hours |
EP0653935B1 (en) * | 1992-08-05 | 2002-05-08 | F.H. FAULDING & CO. LIMITED | Pelletised pharmaceutical composition |
CA2148465C (en) * | 1992-11-06 | 1999-11-02 | Minenobu Okayama | Oral pharmaceutical preparation releasable in the lower digestive tract |
US5358502A (en) * | 1993-02-25 | 1994-10-25 | Pfizer Inc | PH-triggered osmotic bursting delivery devices |
ES2149250T3 (es) * | 1993-04-23 | 2000-11-01 | Novartis Ag | Dispositivo para la administracion de medicamentos con liberacion controlada. |
US6204243B1 (en) | 1993-09-01 | 2001-03-20 | Novatis Ag | Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis |
DE4329503A1 (de) * | 1993-09-01 | 1995-03-02 | Galenik Labor Freiburg Gmbh | Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa |
US6039975A (en) * | 1995-10-17 | 2000-03-21 | Hoffman-La Roche Inc. | Colon targeted delivery system |
NZ325201A (en) * | 1995-12-21 | 1998-11-25 | Ferring Farma Lab | Modified release oral pharmaceutical composition containing 5-asa and method for the treatment of bowel diseases |
US8071128B2 (en) | 1996-06-14 | 2011-12-06 | Kyowa Hakko Kirin Co., Ltd. | Intrabuccally rapidly disintegrating tablet and a production method of the tablets |
US5891474A (en) | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
US5788987A (en) * | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
DE19732903A1 (de) | 1997-07-30 | 1999-02-04 | Falk Pharma Gmbh | Pellet-Formulierung zur Behandlung des Intestinaltraktes |
DE19845358A1 (de) * | 1998-10-02 | 2000-04-06 | Roehm Gmbh | Überzogene Arzneiformen mit kontrollierter Wirkstoffabgabe |
NZ513037A (en) | 1999-01-29 | 2003-05-30 | Disphar Internat B | Coated sustained release pharmaceutical composition for the release of an agent in the gastrointestinal tract |
TWI249519B (en) | 2000-08-29 | 2006-02-21 | Nobex Corp | Immunoregulatory compounds and derivatives and methods of treating diseases therewith |
CA2359812C (en) | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
US20040105886A1 (en) * | 2001-02-16 | 2004-06-03 | Chih-Ming Chen | Divalproex sodium tablets |
US6610326B2 (en) | 2001-02-16 | 2003-08-26 | Andrx Corporation | Divalproex sodium tablets |
US20030190360A1 (en) * | 2001-03-13 | 2003-10-09 | Baichwal Anand R. | Chronotherapeutic dosage forms containing glucocorticosteroid and methods of treatment |
SE0102888D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0102887D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
SE0102886D0 (sv) * | 2001-08-29 | 2001-08-29 | Astrazeneca Ab | New formulation |
US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
US9358214B2 (en) * | 2001-10-04 | 2016-06-07 | Adare Pharmaceuticals, Inc. | Timed, sustained release systems for propranolol |
US6500454B1 (en) * | 2001-10-04 | 2002-12-31 | Eurand Pharmaceuticals Ltd. | Timed, sustained release systems for propranolol |
US8282955B2 (en) | 2001-10-15 | 2012-10-09 | Ferring B.V. | Method for the preparation of a pharmaceutical composition comprising 5-aminosalicylic acid for use in treatment of ulcerative colitis and Crohn's disease |
US20030207846A1 (en) * | 2002-01-07 | 2003-11-06 | Pharmacia Corporation | Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin |
US7022342B2 (en) | 2002-03-28 | 2006-04-04 | Andrx Corporation, Inc. | Controlled release oral dosage form of beta-adrenergic blocking agents |
AU2003230805A1 (en) * | 2002-04-05 | 2003-10-27 | Penwest Pharmaceuticals Co. | Sustained release metoprolol formulations |
US8367111B2 (en) | 2002-12-31 | 2013-02-05 | Aptalis Pharmatech, Inc. | Extended release dosage forms of propranolol hydrochloride |
EP1589957A1 (en) * | 2003-02-05 | 2005-11-02 | IPCA Laboratories Limited | Pharmaceutical compositions and process of production thereof |
US20070042143A1 (en) | 2003-04-23 | 2007-02-22 | Ferring B.V. | Sachet for a pharmaceutical composition |
US7314640B2 (en) * | 2003-07-11 | 2008-01-01 | Mongkol Sriwongjanya | Formulation and process for drug loaded cores |
US20050032879A1 (en) * | 2003-08-07 | 2005-02-10 | Temple Okarter | Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases |
US20050118267A1 (en) * | 2003-09-19 | 2005-06-02 | Penwest Pharmaceuticals Co. | Chronotherapeutic dosage forms |
WO2005027878A1 (en) * | 2003-09-19 | 2005-03-31 | Penwest Pharmaceuticals Co. | Delayed released dosage forms |
EP1547601A1 (en) * | 2003-12-23 | 2005-06-29 | Ferring B.V. | Coating method |
US20060003001A1 (en) * | 2004-02-11 | 2006-01-05 | John Devane | Chronotherapeutic compositions and methods of their use |
PL1773767T3 (pl) | 2004-07-07 | 2016-07-29 | Biocon Ltd | Synteza azowo związanych związków immunoregulacyjnych |
US8747895B2 (en) | 2004-09-13 | 2014-06-10 | Aptalis Pharmatech, Inc. | Orally disintegrating tablets of atomoxetine |
US9884014B2 (en) | 2004-10-12 | 2018-02-06 | Adare Pharmaceuticals, Inc. | Taste-masked pharmaceutical compositions |
EP2417969A1 (en) | 2004-10-21 | 2012-02-15 | Aptalis Pharmatech, Inc. | Taste-masked pharmaceutical compositions with gastrosoluble pore-formers |
US8481565B2 (en) | 2004-12-27 | 2013-07-09 | Eisai R&D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
US9161918B2 (en) | 2005-05-02 | 2015-10-20 | Adare Pharmaceuticals, Inc. | Timed, pulsatile release systems |
US20070087056A1 (en) * | 2005-08-09 | 2007-04-19 | Claudia Guthmann | Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility |
US20070053983A1 (en) * | 2005-09-06 | 2007-03-08 | Girish Jain | Extended release compositions of metoprolol succinate |
CA2640876A1 (en) * | 2005-12-23 | 2007-12-13 | Medichem, S.A. | Process for the preparation of metoprolol and its salts |
US20090028944A1 (en) * | 2007-07-16 | 2009-01-29 | Balaji Sathurappan | Pharmaceutical compositions comprising mesalamine |
US20090036414A1 (en) * | 2007-08-02 | 2009-02-05 | Mutual Pharmaceutical Company, Inc. | Mesalamine Formulations |
US20090062191A1 (en) * | 2007-08-29 | 2009-03-05 | Kiel Laboratories, Inc. | Composition for maintaining gastrointestinal homeostasis |
US20090214665A1 (en) * | 2008-02-26 | 2009-08-27 | Lai Felix S | Controlled Release Muscarinic Receptor Antagonist Formulation |
NZ592049A (en) | 2008-10-03 | 2012-11-30 | Falk Pharma Gmbh | Compositions and methods for the treatment of bowel diseases with granulated mesalamine |
PL2255791T3 (pl) | 2009-04-03 | 2012-05-31 | Zakl Farmaceutyczne Polpharma Sa | Kompozycja farmaceutyczna o przedłużonym uwalnianiu zawierająca bursztynian metoprololu |
CN102008457B (zh) * | 2009-09-04 | 2014-04-02 | 北京天衡药物研究院 | 酒石酸美托洛尔骨架缓释片 |
JP5309262B2 (ja) | 2009-12-02 | 2013-10-09 | アプタリス ファーマ リミテッド | フェキソフェナジン・マイクロカプセル及びそれを含む組成物 |
IL210279A0 (en) | 2009-12-25 | 2011-03-31 | Dexcel Pharma Technologies Ltd | Extended release compositions for high solubility, high permeability acdtive pharmaceutical ingredients |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2099402A (en) * | 1934-01-17 | 1937-11-16 | Pratt Food Company | Pill or tablet |
DE1228757B (de) * | 1962-06-28 | 1966-11-17 | Haessle Ab | Verfahren zur Herstellung eines in Wasser und Magensaft rasch zerfallenden UEberzuges auf festen Arzneiformen |
DE1204363B (de) * | 1963-09-10 | 1965-11-04 | Hoffmann La Roche | Verfahren zur Herstellung einer oralen Arzneizubereitung, die ihren Wirkstoff erst im Ileum abgibt |
US3483221A (en) * | 1964-09-10 | 1969-12-09 | Ciba Geigy Corp | 1 - (isopropylamino)-2-hydroxy-3-(alkenyloxyphenoxy) - propanes and the salts thereof |
NL130749C (sv) * | 1964-09-10 | |||
AT270071B (de) * | 1966-08-12 | 1969-04-10 | Roehm & Haas Gmbh | Dragierlack für Arzneiformen |
US3629237A (en) * | 1968-09-12 | 1971-12-21 | Shinetsu Chemical Co | Compositions useful as enteric coatings and method for preparing acid phthalates of cellulose ethers for them |
SE384853B (sv) * | 1972-04-04 | 1976-05-24 | Haessle Ab | Forfarande for framstellning av nya aminer |
SE354851B (sv) * | 1970-02-18 | 1973-03-26 | Haessle Ab | |
US3909444A (en) * | 1971-08-05 | 1975-09-30 | Ncr Co | Microcapsule |
US4145442A (en) * | 1972-04-04 | 1979-03-20 | Aktiebolaget Hassle | Phenoxy-hydroxypropylamines, their preparation, and method and pharmaceutical preparations for treating cardiovascular diseases |
IL43853A0 (en) * | 1973-02-16 | 1974-03-14 | Sparamedica Ag | Pharmaceutical compositions and their manufacture |
JPS5518694B2 (sv) * | 1973-04-02 | 1980-05-21 | ||
GB1413186A (en) * | 1973-06-27 | 1975-11-12 | Toyo Jozo Kk | Process for encapsulation of medicaments |
SE385693B (sv) * | 1973-10-08 | 1976-07-19 | Haessle Ab | Forfarande for framstellning av nya aminer |
SE388849B (sv) * | 1974-02-14 | 1976-10-18 | Haessle Ab | Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan |
JPS5512411B2 (sv) * | 1974-03-12 | 1980-04-02 | ||
ZA754241B (en) * | 1974-11-01 | 1976-06-30 | Haessle Ab | New amines |
SE402765B (sv) * | 1975-06-04 | 1978-07-17 | Haessle Ab | Forfarande for framstellning av en ny hjertaktiv forening |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
DE2645710C2 (de) * | 1976-10-09 | 1985-06-27 | Merck Patent Gmbh, 6100 Darmstadt | Phenoxy-amino-propanole, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitung |
US4218433A (en) * | 1977-03-03 | 1980-08-19 | Nippon Kayaku Kabushiki Kaisha | Constant-rate eluting tablet and method of producing same |
GB1576376A (en) * | 1977-03-30 | 1980-10-08 | Benzon As Alfred | Multiple-unit drug dose |
DE2905134A1 (de) * | 1978-02-17 | 1979-08-23 | Degussa | Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest |
SE426548B (sv) * | 1978-12-05 | 1983-01-31 | Haessle Ab | Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer |
GB2051574B (en) * | 1979-05-10 | 1984-01-18 | Kyoto Pharma Ind | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
FR2471186A1 (fr) * | 1979-12-10 | 1981-06-19 | Roussel Uclaf | Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation |
SE8003805L (sv) * | 1980-05-21 | 1981-11-22 | Haessle Ab | En farmaceutisk beredning med forbettrade utlosningsegenskap |
JPS57171428A (en) * | 1981-04-13 | 1982-10-22 | Sankyo Co Ltd | Preparation of coated solid preparation |
DE3264867D1 (en) * | 1981-04-27 | 1985-08-29 | Haessle Ab | New pharmaceutical preparation |
ZA825384B (en) * | 1981-07-31 | 1983-05-25 | Tillott J B Ltd | Orally administrable pharmaceutical compositions |
DK150008C (da) * | 1981-11-20 | 1987-05-25 | Benzon As Alfred | Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat |
DE3208791A1 (de) * | 1982-03-11 | 1983-09-22 | Röhm GmbH, 6100 Darmstadt | Verfahren zum ueberziehen von arzneiformen mittes eines in wasser dispergierten ueberzugsmittels |
EP0094117A3 (en) * | 1982-05-06 | 1984-08-01 | The Procter & Gamble Company | Therapeutic granules |
US4415547A (en) * | 1982-06-14 | 1983-11-15 | Sterling Drug Inc. | Sustained-release pharmaceutical tablet and process for preparation thereof |
JPS5920219A (ja) * | 1982-07-26 | 1984-02-01 | Shin Etsu Chem Co Ltd | 腸溶性コ−テイング製剤の製造方法 |
US4578075A (en) * | 1982-12-20 | 1986-03-25 | Alza Corporation | Delivery system housing a plurality of delivery devices |
US4681583A (en) * | 1982-12-20 | 1987-07-21 | Alza Corporation | System for dispersing drug in biological environment |
JPS59193831A (ja) * | 1983-04-18 | 1984-11-02 | Sankyo Co Ltd | 腸溶性製剤の製造法 |
US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
DE3486448T2 (de) * | 1983-11-14 | 1997-10-09 | Columbia Lab Inc | Bioadhäsive Mittel |
US4623588A (en) * | 1984-02-06 | 1986-11-18 | Biotek, Inc. | Controlled release composite core coated microparticles |
DE3405378A1 (de) * | 1984-02-15 | 1985-08-22 | Röhm GmbH, 6100 Darmstadt | Arzneimittelueberzug |
-
1984
- 1984-01-10 SE SE8400085A patent/SE457505B/sv not_active IP Right Cessation
-
1985
- 1985-01-08 DE DE8585850007T patent/DE3572767D1/de not_active Expired
- 1985-01-08 EP EP85850007A patent/EP0148811B1/en not_active Expired
- 1985-01-08 AT AT85850007T patent/ATE46080T1/de not_active IP Right Cessation
- 1985-01-08 EP EP88850123A patent/EP0293347B1/en not_active Expired
- 1985-01-08 AT AT88850123T patent/ATE77077T1/de not_active IP Right Cessation
- 1985-01-08 DE DE8888850123T patent/DE3586206T2/de not_active Expired - Lifetime
- 1985-01-10 US US06/690,197 patent/US4780318A/en not_active Expired - Lifetime
-
1986
- 1986-01-17 SE SE8600202A patent/SE462529B/sv not_active IP Right Cessation
-
1988
- 1988-03-25 US US07/172,897 patent/US5001161A/en not_active Expired - Lifetime
-
1995
- 1995-01-09 SG SG2295A patent/SG2295G/en unknown
- 1995-02-23 HK HK24995A patent/HK24995A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SE8600202L (sv) | 1986-01-17 |
ATE77077T1 (de) | 1992-06-15 |
SE8400085L (sv) | 1985-07-11 |
EP0148811B1 (en) | 1989-09-06 |
US4780318A (en) | 1988-10-25 |
SG2295G (en) | 1995-06-16 |
SE457505B (sv) | 1989-01-09 |
EP0148811A1 (en) | 1985-07-17 |
SE462529B (sv) | 1990-07-09 |
HK24995A (en) | 1995-03-03 |
EP0293347A1 (en) | 1988-11-30 |
US5001161A (en) | 1991-03-19 |
ATE46080T1 (de) | 1989-09-15 |
SE8400085D0 (sv) | 1984-01-10 |
EP0293347B1 (en) | 1992-06-10 |
DE3586206T2 (de) | 1992-12-24 |
DE3572767D1 (en) | 1989-10-12 |
DE3586206D1 (de) | 1992-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE8400085L (sv) | Farmaceutisk komposition (ii) | |
DE3587577D1 (de) | Antimykotische pharmazeutische Präparate. | |
FI862094A (fi) | Bornerande terapeutisk komposition. | |
DE3586545D1 (de) | Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen. | |
DE3677276D1 (de) | Photopolymerisierbare zusammensetzung. | |
DE3689246D1 (de) | Physiologisch aktives Polypeptid BUF-3. | |
DE3586503D1 (de) | Photohaertbare zusammensetzung. | |
DE3580304D1 (de) | Arzneimittel. | |
DE3674593D1 (de) | Medizinische zusammensetzung. | |
DE3587705D1 (de) | Kombinierte Düngemittelzusammensetzung. | |
FI850826A0 (fi) | Modifierad b-staerkelse ur vete foer limmedel avsedda foer wellpapperprodukter. | |
DE3669105D1 (de) | Therapeutische zusammensetzung. | |
NO862439D0 (no) | Farmasoeytiske preparater. | |
IT1213453B (it) | Composizione farmaceutica. | |
DE3586765D1 (de) | Immunogenische hav-peptide. | |
DE3579911D1 (de) | Stabiles grf-praeparat. | |
NO873886D0 (no) | Topiske antiinflammatoriske preparater. | |
IT8521235A0 (it) | Composti farmacologicamente attivi. | |
FI855131A (fi) | 8-acylaminoergoliner, deras framstaellning och farmaceutiska sammansaettningar innehaollande desamma. | |
DE3669656D1 (de) | Azanaphthalene enthaltende arzneimittelzusammensetzungen. | |
DE3577108D1 (de) | Modifizierte urokinase-zusammensetzung. | |
DK86785A (da) | Bromcryptinpraeparater | |
FI850803L (fi) | Aminodiarylsulfoxiderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska och pesticida foereningar. | |
DE3680711D1 (de) | Photopolymerisierbare zusammensetzung. | |
IT8783379A0 (it) | Composizioni farmaceutiche antimicotiche. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8600202-9 Format of ref document f/p: F |
|
NUG | Patent has lapsed |